1 of 1
Story summary
- A Journal of Medical Internet Research study finds semaglutide users tolerate nausea and vomiting because of weight loss benefits.
- Morgan James, senior researcher, notes users prioritize weight loss over discomfort.
- The study analyzed 60 reviews from Drugs.com.
- 62% reported side effects, and about 67% experienced weight loss or reduced appetite.
- Those who did not lose weight were more likely to discontinue, and future research may examine sex differences.
